Tubulis Touts Transatlantic Plans As Cash Rolls In

 
• By Kevin Grogan

The German biotech is benefitting from the heat in the antibody-drug conjugate space and has concluded an upsized series B2 financing for €128m.

Tubulis management
Tubulis management team (l-r): Günter Fingerle-Rowson (CMO), Jonas Helma-Smets (CSO), Dominik Schumacher (CEO), Ingo Lehrke (CBO) and Björn Hock (CDO) • Source: Tubulis

More from Financing

More from Business